Distinct Structural Flexibility Within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets

doi 10.1101/2020.04.17.047548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

SARS-CoV-2 Invades Host Cells via a Novel Route: CD147-spike Protein

2020English

The First-In-Class Peptide Binder to the SARS-CoV-2 Spike Protein

2020English

Human Monoclonal Antibodies Block the Binding of SARS-CoV-2 Spike Protein to Angiotensin Converting Enzyme 2 Receptor

2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

De Novo Design of High-Affinity Antibody Variable Regions (scFv) Against the SARS-CoV-2 Spike Protein

2020English

Deducing the N- And O- Glycosylation Profile of the Spike Protein of Novel Coronavirus SARS-CoV-2

2020English

Computational Identification of Small Interfering RNA Targets in SARS-CoV-2

Virologica Sinica
2020English

In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy